Outcome of pregnancies in women with treated or untreated hyperprolactinemia

European journal of obstetrics, gynecology, and reproductive biology, 63(2), 143-146

DOI 10.1016/0301-2115(95)02257-0 PMID 8903770 Source

Abstract

The outcome of 103 pregnancies in 64 women with constant hyperprolactinemia was evaluated. Seventy-eight pregnancies had been induced with bromocriptine and 25 occurred without any treatment. In all, 66% of the pregnancies ended in delivery, 17% in miscarriage, 10% in tubal pregnancy and 7% in induced abortion. The pregnancy of women with untreated hyperprolactinemia was more frequently ectopic when compared to those in women treated by bromocriptine. Obstetric complications as well as signs of tumoral enlargement during pregnancy were rare in hyperprolactinemic women treated or untreated with bromocriptine. Untreated hyperprolactinemia as a risk factor in tubal pregnancy is proposed.

Topics

hyperprolactinemia pregnancy outcomes, bromocriptine pregnancy treatment, high prolactin infertility pregnancy, ectopic pregnancy hyperprolactinemia risk, prolactin disorder miscarriage rates, untreated hyperprolactinemia tubal pregnancy, bromocriptine ovulation induction pregnancy, prolactinoma pregnancy complications, elevated prolactin pregnancy success, hyperprolactinemia treatment fertility outcomes, prolactin levels pregnancy loss, dopamine agonist pregnancy rates

Cite this article

Rossi, A. M., Vilska, S., & Heinonen, P. K. (1995). Outcome of pregnancies in women with treated or untreated hyperprolactinemia. *European journal of obstetrics, gynecology, and reproductive biology*, *63*(2), 143-146. https://doi.org/10.1016/0301-2115(95)02257-0

Related articles